S32 LSE Week ended 07 Aug 2026

Weekly Investor Report

South32 Limited · Basic Materials · Other Industrial Metals & Mining

Open interactive chart View report data
Latest close 260.0 GBP
9.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 14.0% above the Trend Line and sits at 96.5% of its 52-week range. The latest completed week returned 9.7%, after a 23.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 56/100. Near-term considerations: price is close to its 52-week high.

Setup score 61 out of 100
Latest Close 260.0 GBP 7 Aug 2026
1W Return 9.7% latest completed week
4W Return 23.2% short-term follow-through
12W Return 16.3% quarterly tape
Trend Breadth 73.1% 38 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 10 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 9.7% Latest completed week; four-week move 23.2%. Indicator stack 44/48 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 56/100 32 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 14.0% above the Trend Line and sits at 96.5% of its 52-week range. The latest completed week returned 9.7%, after a 23.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5412-week average 0.60

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.54Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1010 reversal markers

No recent accumulation markers. 10 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 23.2% over four weeks, 16.3% over 12 weeks, and 76.4% over one year. The current trend has remained active for 1 consecutive weeks.

Performance by holding period

1W9.7%
4W23.2%
12W16.3%
26W13.3%
52W76.4%
Active trend streak1 weeks
Active weeks in one year38
Trend breadth73.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.39Latest activity-pressure read.
Pressure change65.9%Four-week change in activity pressure.
Leadership23.20Latest relative-leadership reading.
RS change268.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 88% Model confidence 70%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength32/100Blend of value, momentum, and quality. Underlying universe rank 69; rank 1 is best.
Value18/100Relative valuation strength. Underlying universe rank 83; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum96/100Medium-term price momentum. Underlying universe rank 5; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework47/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
54.7x
Price divided by trailing earnings.
Price / sales
2.0x
Market value relative to trailing revenue.
EV / EBITDA
8.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
43.6%
Gross profit retained from each unit of revenue.
Operating margin
16.3%
Operating profit retained from revenue.
Free-cash-flow margin
5.7%
Free cash flow generated from revenue.
Return on invested capital
7.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
17.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.9%
Cash dividends relative to market value.
Buyback yield
0.5%
Net share repurchases relative to market value.
Shareholder yield
2.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 32 relevant articles.

11 positive · 20 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.9%Distance below the 52-week high.
13-week volatility7.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+15.2%Week of 24 Jul.
Worst week-9.8%Week of 20 Mar.
Latest week+9.7%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains6
Flat weeks0
Modest losses6
Sharp losses7
Recent vol7.1%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew5.2% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape55/100

Trend, activity pressure, participation, and risk combine to a 55/100 tape read.

 Indicator analysis46/100

Latest 12-week confirmation: trend 8/12, activity pressure 0/12, relative leadership 12/12.

Activity pressure 0.54; 10 reversal markers Factors38/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 38 SVQF47/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 137.5 of 260 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 32 relevant articles.

South32 (ASX:S32): Why Is Stock Under Pressure Today? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026260.0 GBP9.7%228.1 GBP177.4 GBP-0.3923.201.7MOn
31 Jul 2026237.0 GBP0.9%225.9 GBP177.0 GBP-0.7713.501.9MOff
24 Jul 2026235.0 GBP15.2%223.9 GBP176.8 GBP-0.9714.652.5MOff
17 Jul 2026204.0 GBP-3.3%222.0 GBP176.6 GBP-1.201.382.0MOff
10 Jul 2026211.0 GBP-2.7%220.8 GBP176.6 GBP-1.146.292.7MOff
3 Jul 2026216.8 GBP5.3%219.6 GBP176.5 GBP-0.957.72191.1KOn
26 Jun 2026205.8 GBP-7.4%218.1 GBP176.4 GBP-0.814.29361.2KOn
19 Jun 2026222.2 GBP-9.1%216.5 GBP176.3 GBP-0.5214.59970.6KOn
12 Jun 2026244.4 GBP1.2%214.2 GBP176.2 GBP-0.3725.47751.2KOn
5 Jun 2026241.4 GBP-5.9%211.3 GBP176.0 GBP-0.4026.14745.0KOn
29 May 2026256.4 GBP11.2%208.2 GBP175.7 GBP-0.3234.421.9MOn
22 May 2026230.6 GBP3.1%204.8 GBP175.4 GBP-0.4921.283.1MOn
15 May 2026223.6 GBP0.4%202.5 GBP175.3 GBP-0.5121.413.9MOn
8 May 2026222.6 GBP3.2%200.1 GBP175.3 GBP-0.4221.135.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context